| |
• Nagardo, the “natural guardian,” due to launch in Europe in autumn 2022;
• Glycolipids obtained from edible mushrooms already in use in the U.S., Australia, New Zealand, and Canada.
“EU approval allows us to continue expanding the global footprint of Nagardo. The preservative is already in use in the U.S., Australia, New Zealand, and Canada,” said Monika Ebener, Global Marketing Director for Natural Antimicrobials at LANXESS. “We’re going to be launching in other markets as well. We are now proud to present our natural guardian in our home market, too.”
EU approval is regarded as the gold standard due to its thorough evaluation process. “This registration means that European beverage producers can now make use of a long-awaited natural preservative that not only reliably and efficiently safeguards product quality but also enables manufacturers to transform their product ranges to suit the emerging trend of consumer awareness and demand for natural ingredients. The use of Nagardo can also help companies to achieve their sustainability targets, partly by reducing the amount of plastic needed for packaging and partly because switching from hot filling or tunnel pasteurization to cold filling with Nagardo cuts energy usage.
Nagardo is used in various beverage categories, which means that a wide-ranging market can depend on the protection offered by this natural preservative.
Nagardo is based on glycolipids obtained from edible mushrooms, which were discovered in a comprehensive screening process encompassing more than 100,000 natural substances. It transpired that they offer the kind of effectiveness that can be found only in nature all that is needed is a dosage as much as 50 times smaller than is the case with commonly used synthetic preservatives. It is currently the most effective natural preservative for non-alcoholic beverages on the market.
Product launched in EU at world-leading drinktec trade show
Nagardo will be launched officially in Europe for the first time at this year’s drinktec (drinktec.com), a trade show that will be taking place in Munich from September 12 to 16.
LANXESS, whose cold sterilization agent Velcorin is among the leading technologies in beverage stabilization, will be there to showcase both technologies together for the first time. Velcorin has proved its worth as a cold sterilization agent, but Ebener pointed out that Nagardo would not be competing for the same market share. Instead, LANXESS, in its capacity as a solution provider, will now be offering the option of adding another string to a producer’s bow as a means of creating customized solutions. It will even be possible to combine Velcorin and Nagardo to provide the perfect protection for beverages.
You can find more detailed information at nagardo.com. Here you can also download the new “Nagardo” product brochure.
About LANXESS
LANXESS (lanxess.com) is a leading specialty chemicals company with sales of EUR 6.8 billion in 2019. The company currently has about 14,400 employees in 33 countries. The core business of LANXESS is the development, manufacturing and marketing of chemical intermediates, additives, specialty chemicals and plastics. LANXESS is listed in the leading sustainability indices Dow Jones Sustainability Index (DJSI World and Europe) and FTSE4Good.
Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.
|
ilona.kawan[.]lanxess.com 
